樂普醫療(300003.SZ):聚乳酸面部填充劑獲得NMPA註冊批准
格隆匯6月3日丨樂普醫療(300003.SZ)公佈,公司自主研發的聚乳酸面部填充劑獲得國家藥品監督管理局(NMPA)註冊批准,註冊證編號:國械注準20253131101。聚乳酸面部填充劑,即“童顏針”,是一種真皮組織填充劑,通過將聚左旋乳酸(PLLA)注射於真皮深層,起到修復外形,矯正輪廓以達到填充溝壑、皺紋的效果。其主要成分聚左旋乳酸(PLLA)是一種微粒注射型粉末,具有優異的生物相容性、可降解性和安全性,可在生物體內降解為二氧化碳和水排出體外,不會對人體造成長期影響。
聚乳酸面部填充劑基於公司可降解材料學平台自主研發生產,在臨牀使用上具備良好的治療效果和較低的副作用發生率,為醫生和消費者提供新的選擇。該產品的成功獲批上市是公司在皮膚科領域的重要里程碑事件,標誌着公司正式進入皮膚科領域,進一步助力公司消費醫療事業的健康發展,預計將對公司業務發展產生積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.